Nihon Kakuyo achieved sales of \u00a5241.8 billion (8.7% increase) and net income attributable to owners of the parent of \u00a524.6 billion (40.7% increase) for the fiscal year ending March 2026. Segments including Mobility & Imaging, Fine Chemicals, and Life Sciences all posted revenue and profit growth.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4272","jir_company_name":"Nihon Kakuyo Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-05-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4272-20260512-01.pdf","jir_short_summary":"Nihon Kakuyo achieved sales of \u00a5241.8 billion (8.7% increase) and net income attributable to owners of the parent of \u00a524.6 billion (40.7% increase) for the fiscal year ending March 2026. Segments including Mobility & Imaging, Fine Chemicals, and Life Sciences all posted revenue and profit growth.","jir_summary":"### Overview of Financial Performance\nNihon Kakuyo recorded net sales of \u00a5241.8 billion (up 8.7% YoY), operating income of \u00a522.4 billion (up 10.1% YoY), and net income attributable to owners of the parent of \u00a524.6 billion (up 40.7% YoY) for the fiscal year ending March 2026. All segments\u2014including Mobility & Imaging, Fine Chemicals, and Life Sciences\u2014achieved increases in revenue and profit, with net income rising sharply due to gains from sale of investment securities and other factors. Sales remained steady across business areas, and profit margins improved.\n\n### Outlook and Impact on Shareholders\nThe company will continue to promote global market expansion and new product launches to increase profitability. As shareholder returns, an annual dividend of \u00a566.00 is planned, along with share buyback and cancellation efforts. The company aims to improve capital efficiency and increase share value, with a forecast for steady performance in the fiscal year ending March 2027.","jir_financial_highlights":"Net Sales: \u00a5241,805 million (YoY +8.7%)\nNet Income Attributable to Owners of the Parent: \u00a524,641 million (YoY +40.7%)\nConsolidated Operating Income: \u00a522,454 million (YoY +10.1%)","jir_category":"","jir_hashtags":"#NihonKakuyo, #IRFinancialResults, #JapaneseStocks","jir_key_figures":"Net Sales: \u00a5241,805 million (YoY +8.7%)\nNet Income Attributable to Owners of the Parent: \u00a524,641 million (YoY +40.7%)\nDividends: \u00a566.00 (annual plan)","jir_meta_title":"\u3010Nihon Kakuyo\u30112026 Financial Results | Sales of \u00a5241.8 billion, Net Income of \u00a524.6 billion","jir_meta_description":"Nihon Kakuyo achieved sales of \u00a5241.8 billion and net income of \u00a524.6 billion for the fiscal year ending March 2026. The company plans to strengthen global expansion and shareholder returns for sustainable growth.","jir_og_title":"\u3010Nihon Kakuyo\u30112026 Financial Results | Sales of \u00a5241.8 billion, Net Income of \u00a524.6 billion","jir_og_description":"Nihon Kakuyo's 2026 financial results record sales of \u00a5241.8 billion and net income of \u00a524.6 billion. Also introduced are future outlook and shareholder return measures.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8762,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-48037","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n